| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |